According to Astellas Pharma's latest financial reports the company's current earnings (TTM) are NZ$0.25 B. In 2023 the company made an earning of NZ$0.19 B a decrease over its 2022 earnings that were of NZ$1.96 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.